Sodium Hydroxide → HCID 66571536, compound
Reaction equation
FC(F)(F)C([N:5]([CH2:21][CH:22]1[CH2:27][CH2:26][N:25]([CH2:28][C:29]2[CH:38]=[CH:37][C:32]([C:33]([O:35]C)=[O:34])=[CH:31][CH:30]=2)[CH2:24][CH2:23]1)[C@@H:6]1[CH2:8][C@H:7]1[C:9]1[CH:14]=[CH:13][C:12]([C:15]2[CH:16]=[N:17][N:18]([CH3:20])[CH:19]=2)=[CH:11][CH:10]=1)=O.[OH-].[Na+]>CO>[CH3:20][N:18]1[CH:19]=[C:15]([C:12]2[CH:13]=[CH:14][C:9]([C@@H:7]3[CH2:8][C@H:6]3[NH:5][CH2:21][CH:22]3[CH2:23][CH2:24][N:25]([CH2:28][C:29]4[CH:30]=[CH:31][C:32]([C:33]([OH:35])=[O:34])=[CH:37][CH:38]=4)[CH2:26][CH2:27]3)=[CH:10][CH:11]=2)[CH:16]=[N:17]1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of methyl 4-((4-((2,2,2-trifluoro-N-(trans-2-(4-(1-methyl-1H-pyrazol-4-yl)phenyl)cyclopropyl)acetamido)methyl)piperidin-1-yl)methyl)benzoate (67 mg, 0.121 mmol) in methanol (2 mL) was added sodium hydroxide (1M, 0.5 mL, 0.500 mmol), and the mixture was stirred at r room temperature for 18 h. The mixture was purified using reverse-phase HPLC. The fractions containing the product as combined, treated with 1N HCl and concentrated. The residue was dried under vacuum to give 25 mg of product (HCl salt) as white solid. MS: (M+H)+=445.4. 1H NMR (400 MHz, DMSO-d6) δ ppm 1.19-1.37 (m, 1H), 1.51-1.72 (m, 3H), 1.88-2.13 (m, 3H), 2.55-2.65 (m, 1H), 2.85-3.05 (m, 4H), 3.12-3.25 (m, 1H), 3.34 (d, J=11.87 Hz, 2H), 4.34 (d, J=5.05 Hz, 2H), 7.11-7.23 (m, 2H), 7.45-7.55 (m, 2H), 7.71-7.81 (m, 2H), 7.83-7.89 (m, 1H), 7.97-8.06 (m, 2H), 8.10-8.18 (m, 1H).
Workup
- customThe mixture was purified
- additionThe fractions containing the product
- additiontreated with 1N HCl
- concentrationconcentrated
- customThe residue was dried under vacuum
Sources & evidence
- ORD record
- ord-2c4e45195cfc4f4c8d4eb9551053b92f
- Source dataset
- uspto-grants-2014_10
- Patent number
- US08853408B2
Reaction notes
Loading…